Chest CT Using Low-concentration Iodine Contrast Media

Launched by JUNG IM JUNG · Jul 21, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of a new type of iodine contrast agent in chest CT scans for patients with lung diseases. The researchers want to find out if using low-concentration iodine contrast, along with lower energy during the scan, can produce clear images that are just as good as those taken with traditional methods. This could potentially make chest CT scans safer and more comfortable for patients.

To be eligible for the trial, participants need to be at least 19 years old, weigh less than 90 kg (about 198 pounds), and have a body mass index (BMI) under 30. They should also be able to undergo a chest CT scan with contrast. However, certain individuals, like those under 18, pregnant women, or those with specific health issues, will not be able to participate. If you join the study, you can expect to undergo a chest CT scan with the new contrast agent and help researchers learn more about its effectiveness.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone
• Exclusion Criteria:
• • 1. Under the age of 18
• • 2. Cases where contrast-enhanced CT cannot be performed
• • 3. Heart failure
• • 4. Pregnancy
• • 5. If patients cannot voluntarily give written consent to participate in this clinical trial
• • 6. In the case of an anatomical deformation that may interfere with image analysis in the previous image
• • 7. Patients with a history of hypersensitivity to IOBRIX, components of IOBRIX, and iodine-based drugs
• • 8. Patients with severe thyroid disease (Iodine may accumulate in the thyroid gland and worsen symptoms.)
• • 9. Those who are judged unsuitable by the tester for other reasons Patients aged 19 years or older, weighing less than 90 kg, and BMI less than 30 who underwent contrast-enhanced chest CT alone